4 ms·
It is in fact too cynical. The company that wanted to sell this drug isn’t the same as the companies selling recurring treatment to people with this disorder. Y
by dodobirdlord 5y ago
It is in fact too cynical. The company that wanted to sell this drug isn’t the same as the companies selling recurring treatment to people with this disorder. Your cynicism has blinded you to the fact that the marketers of this drug do not have any economic motivation to do what you are suggesting. Their economic motivation is to sell the tiny number of doses required to treat everyone in the first world (2,000-3,000) at a price high enough to recover their investment and make a profit.
- mmazing 5y agoWhy not look for funding from the many sources of grants and charities that might not care about economic motivation? Your comment seems very defeatist. Actually this whole thread seems defeatist.
- s1artibartfast 5y agoThere are not many charities and grants willing to shell out a million dollars to improve one persons quality of life.